The Experts below are selected from a list of 15120 Experts worldwide ranked by ideXlab platform
Pilato E - One of the best experts on this subject based on the ideXlab platform.
-
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital.
2005Co-Authors: Nardo B, Beltempo P, Montalti R, Bertelli R, Cavallari G, Ercolani G, Lauro A, Grazi G, Pilato EAbstract:AIM: We report a series of patients who underwent combined heart-Kidney transplantation (CHKT) and combines liver-Kidney transplantation (CLKT) at a single center. METHODS: From January 1997 to October 2004, 13 CLKT and 2 CHKT were performed. The CLKT indications were as follows: Polycystic Disease (2), Kidney Polycystic Disease associated with Caroli (1) and cirrhosis-hepatitis C virus (HCVs) (1), chronic glomerulonephritis with cirrhosis-HCV (4), and other Diseases (5). From December 2003 to October 2004, 2 patients underwent CHKT for idiopathic cardiomyopathy plus glomerulonephritis and ischemic cardiomyopathy associated with vascular nephritis. RESULTS: In the CLKT group, 1 patient had acute rejection involving both liver and Kidney grafts, whereas 1 patient had liver rejection and another 1 had Kidney rejection alone. Of the 13 patients, 10 are alive with a mean survival of 583 days (range, 36-2688 days); 2 patients died within 1 month of transplantation (both with Polycystic Disease) due to ARDS and MOF. Another patient died 6 years and 9 months after CLKT of metastasis from a de novo tumor. In the CHKT group, no patient suffered heart-Kidney rejection. They are all alive at 333 and 116 days, with heart and Kidney allografts functioning well. CONCLUSION: In the CLKT group, the worst results were for patients with Polycystic Disease, in whom a more rigorous selection is necessary because of greater technical difficulties. For the remaining patients we had acceptable complications and excellent long-term results. In selected cases, CHKT can provide long-term graft function and patient survival. Our experience indicates that end-stage Kidney failure combined with liver or heart failure does not necessarily preclude dual-organ transplantation
Nardo B - One of the best experts on this subject based on the ideXlab platform.
-
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital.
2005Co-Authors: Nardo B, Beltempo P, Montalti R, Bertelli R, Cavallari G, Ercolani G, Lauro A, Grazi G, Pilato EAbstract:AIM: We report a series of patients who underwent combined heart-Kidney transplantation (CHKT) and combines liver-Kidney transplantation (CLKT) at a single center. METHODS: From January 1997 to October 2004, 13 CLKT and 2 CHKT were performed. The CLKT indications were as follows: Polycystic Disease (2), Kidney Polycystic Disease associated with Caroli (1) and cirrhosis-hepatitis C virus (HCVs) (1), chronic glomerulonephritis with cirrhosis-HCV (4), and other Diseases (5). From December 2003 to October 2004, 2 patients underwent CHKT for idiopathic cardiomyopathy plus glomerulonephritis and ischemic cardiomyopathy associated with vascular nephritis. RESULTS: In the CLKT group, 1 patient had acute rejection involving both liver and Kidney grafts, whereas 1 patient had liver rejection and another 1 had Kidney rejection alone. Of the 13 patients, 10 are alive with a mean survival of 583 days (range, 36-2688 days); 2 patients died within 1 month of transplantation (both with Polycystic Disease) due to ARDS and MOF. Another patient died 6 years and 9 months after CLKT of metastasis from a de novo tumor. In the CHKT group, no patient suffered heart-Kidney rejection. They are all alive at 333 and 116 days, with heart and Kidney allografts functioning well. CONCLUSION: In the CLKT group, the worst results were for patients with Polycystic Disease, in whom a more rigorous selection is necessary because of greater technical difficulties. For the remaining patients we had acceptable complications and excellent long-term results. In selected cases, CHKT can provide long-term graft function and patient survival. Our experience indicates that end-stage Kidney failure combined with liver or heart failure does not necessarily preclude dual-organ transplantation
Beltempo P - One of the best experts on this subject based on the ideXlab platform.
-
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital.
2005Co-Authors: Nardo B, Beltempo P, Montalti R, Bertelli R, Cavallari G, Ercolani G, Lauro A, Grazi G, Pilato EAbstract:AIM: We report a series of patients who underwent combined heart-Kidney transplantation (CHKT) and combines liver-Kidney transplantation (CLKT) at a single center. METHODS: From January 1997 to October 2004, 13 CLKT and 2 CHKT were performed. The CLKT indications were as follows: Polycystic Disease (2), Kidney Polycystic Disease associated with Caroli (1) and cirrhosis-hepatitis C virus (HCVs) (1), chronic glomerulonephritis with cirrhosis-HCV (4), and other Diseases (5). From December 2003 to October 2004, 2 patients underwent CHKT for idiopathic cardiomyopathy plus glomerulonephritis and ischemic cardiomyopathy associated with vascular nephritis. RESULTS: In the CLKT group, 1 patient had acute rejection involving both liver and Kidney grafts, whereas 1 patient had liver rejection and another 1 had Kidney rejection alone. Of the 13 patients, 10 are alive with a mean survival of 583 days (range, 36-2688 days); 2 patients died within 1 month of transplantation (both with Polycystic Disease) due to ARDS and MOF. Another patient died 6 years and 9 months after CLKT of metastasis from a de novo tumor. In the CHKT group, no patient suffered heart-Kidney rejection. They are all alive at 333 and 116 days, with heart and Kidney allografts functioning well. CONCLUSION: In the CLKT group, the worst results were for patients with Polycystic Disease, in whom a more rigorous selection is necessary because of greater technical difficulties. For the remaining patients we had acceptable complications and excellent long-term results. In selected cases, CHKT can provide long-term graft function and patient survival. Our experience indicates that end-stage Kidney failure combined with liver or heart failure does not necessarily preclude dual-organ transplantation
Montalti R - One of the best experts on this subject based on the ideXlab platform.
-
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital.
2005Co-Authors: Nardo B, Beltempo P, Montalti R, Bertelli R, Cavallari G, Ercolani G, Lauro A, Grazi G, Pilato EAbstract:AIM: We report a series of patients who underwent combined heart-Kidney transplantation (CHKT) and combines liver-Kidney transplantation (CLKT) at a single center. METHODS: From January 1997 to October 2004, 13 CLKT and 2 CHKT were performed. The CLKT indications were as follows: Polycystic Disease (2), Kidney Polycystic Disease associated with Caroli (1) and cirrhosis-hepatitis C virus (HCVs) (1), chronic glomerulonephritis with cirrhosis-HCV (4), and other Diseases (5). From December 2003 to October 2004, 2 patients underwent CHKT for idiopathic cardiomyopathy plus glomerulonephritis and ischemic cardiomyopathy associated with vascular nephritis. RESULTS: In the CLKT group, 1 patient had acute rejection involving both liver and Kidney grafts, whereas 1 patient had liver rejection and another 1 had Kidney rejection alone. Of the 13 patients, 10 are alive with a mean survival of 583 days (range, 36-2688 days); 2 patients died within 1 month of transplantation (both with Polycystic Disease) due to ARDS and MOF. Another patient died 6 years and 9 months after CLKT of metastasis from a de novo tumor. In the CHKT group, no patient suffered heart-Kidney rejection. They are all alive at 333 and 116 days, with heart and Kidney allografts functioning well. CONCLUSION: In the CLKT group, the worst results were for patients with Polycystic Disease, in whom a more rigorous selection is necessary because of greater technical difficulties. For the remaining patients we had acceptable complications and excellent long-term results. In selected cases, CHKT can provide long-term graft function and patient survival. Our experience indicates that end-stage Kidney failure combined with liver or heart failure does not necessarily preclude dual-organ transplantation
Bertelli R - One of the best experts on this subject based on the ideXlab platform.
-
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital.
2005Co-Authors: Nardo B, Beltempo P, Montalti R, Bertelli R, Cavallari G, Ercolani G, Lauro A, Grazi G, Pilato EAbstract:AIM: We report a series of patients who underwent combined heart-Kidney transplantation (CHKT) and combines liver-Kidney transplantation (CLKT) at a single center. METHODS: From January 1997 to October 2004, 13 CLKT and 2 CHKT were performed. The CLKT indications were as follows: Polycystic Disease (2), Kidney Polycystic Disease associated with Caroli (1) and cirrhosis-hepatitis C virus (HCVs) (1), chronic glomerulonephritis with cirrhosis-HCV (4), and other Diseases (5). From December 2003 to October 2004, 2 patients underwent CHKT for idiopathic cardiomyopathy plus glomerulonephritis and ischemic cardiomyopathy associated with vascular nephritis. RESULTS: In the CLKT group, 1 patient had acute rejection involving both liver and Kidney grafts, whereas 1 patient had liver rejection and another 1 had Kidney rejection alone. Of the 13 patients, 10 are alive with a mean survival of 583 days (range, 36-2688 days); 2 patients died within 1 month of transplantation (both with Polycystic Disease) due to ARDS and MOF. Another patient died 6 years and 9 months after CLKT of metastasis from a de novo tumor. In the CHKT group, no patient suffered heart-Kidney rejection. They are all alive at 333 and 116 days, with heart and Kidney allografts functioning well. CONCLUSION: In the CLKT group, the worst results were for patients with Polycystic Disease, in whom a more rigorous selection is necessary because of greater technical difficulties. For the remaining patients we had acceptable complications and excellent long-term results. In selected cases, CHKT can provide long-term graft function and patient survival. Our experience indicates that end-stage Kidney failure combined with liver or heart failure does not necessarily preclude dual-organ transplantation
